Medscape November 10, 2023

(Reuters) – The U.S. Food and Drug Administration (FDA) on Thursday cleared an over-the-counter at-home COVID-19 antigen test made by Acon Laboratories.

Acon’s test is the second coronavirus test to get marketing authorization using the agency’s traditional premarket review pathway and the first indicated for use in children under 18, the health regulator said.

The FDA had...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article